The NHS Cancer Programme invites innovations or new approaches that will detect cancers earlier and increase the proportion diagnosed at stage one or two.

The competition aims to fast-track high quality, proven, late-stage innovations into front-line settings, as well as address implementation evidence gaps.

Innovations will be 100% funded up to the total value of £4 million  (excluding VAT) over a maximum of 24 months.

Please sign up for the:

  • Online Briefing Webinar: Tuesday 6 February 2024, 3pm-5pm Sign up here
  • Online Innovation Matchmaking event on Tuesday 12 March 2024, 2pm- 5pm Sign up here.

Applications will open on Monday 8 April 2024 and close on Wednesday 29 May 2024, 1pm. Full details and Challenge brief on the Competition page.

The competition is open to:

  • All types of innovation, including but not limited to, medical devices, in vitro diagnostics, digital health solutions, behavioural interventions, software, artificial intelligence, and new models of care.
  • Single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities and NHS Foundation Trusts, as long as a strong implementation and commercial strategy is provided.
  • Organisations based outside the UK or EU with innovations in remit for this call can apply as subcontractors of a lead UK/EU based organisation or via a UK or EU subsidiary.

The third in a series of competitions, to date over £24.5 million has been funded through the NHS Cancer Programme Innovation Open Calls across 14 projectsimpacting 30,000 patients so far.

The call is developed and led by the NHS Cancer Programme and supported by SBRI Healthcare and the Accelerated Access Collaborative. The support of Cancer Alliances plays a key role in enabling spread and adoption. The competition supports the ambitions of the NHS Long Term Plan (LTP) that by 2028, 75% of people will be diagnosed earlier, at stage one or two, and an extra 55,000 people will survive cancer for five years or more.

Key Dates:

  • Online launch event: Tuesday 6 February 2024, 3pm-5pm. Sign up
  • Online innovation matchmaking event: Tuesday 12 March 2024, 2pm-5pm. Sign up
  • Workshop: Thursday 4 April 2024, 10am-12pm
  • Application Opens: Monday 8 April 2024
  • Q&A: Thursday 18 April 2024, 11am-12.30pm
  • Deadline for applications: Wednesday 29 May 2024, 1pm
  • Assessment: May/June 2024
  • Peer review (if shortlisted): July/September 2024
  • Interview Panel(s): Wednesday 2 and Thursday 3 October 2024
  • Contracts awarded: October/November 2024

To learn more about the NHS Cancer Programme innovation open call, click here. 

Latest Opportunities

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

UKRI unveils new £9 million proof-of-concept fund

The UKRI Proof of Concept funding opportunity aims to support and accelerate the development of…

Peer advice on “demand forecasting strategies”

An established Midlands-based health manufacturer is keen to hear from others about their demand forecasting…

Latest News

Illuminating biology: Advanced imaging and computational techniques transforming medical research at the University of Warwick

Advances in imaging and computational techniques are enabling researchers to discover more than ever before…

From firefighting to future-proofing: Why predictive compliance is key in medical device software

By Medilink Midlands Member Coauthor by Hindsight In today’s fast-paced and highly regulated world of…

IMed Consultancy new whitepaper reveals how to transform gruelling PMS procedures into commercial benefit

IMed Consultancy’s new free whitepaper, “PMS from pain to potential: more than just ticking a…